Kind Pharmaceuticals Llc

This study tests a new drug called AND017 for cancer patients who develop anemia (low red blood cells) from chemotherapy. About 36 adults with certain cancers will receive the drug for 6 weeks to see if it safely raises hemoglobin levels and reduces the need for blood transfusion…

This study tests a new drug called AND017 for treating anemia (low red blood cells) in people with cancer who are not receiving chemotherapy. The goal is to see if different doses can safely raise hemoglobin levels over 6 weeks. About 36 adults with certain cancers and low hemogl…